Disruption of the 5-lipoxygenase pathway attenuates atherogenesis consequent to COX-2 deletion in mice

Zhou Yu1, Irene Crichton, Soon Yew Tang

  • 1Institute for Translational Medicine and Therapeutics, University of Pennsylvania, Philadelphia, PA, 19104, USA.

Insights

Nonsteroidal anti-inflammatory drugs (NSAIDs) increase cardiovascular risk by suppressing cyclooxygenase 2 (COX-2). Postnatal COX-2 deletion in mice accelerated atherosclerosis, suggesting a mechanism for NSAID-related cardiovascular hazards.

Area of Science:

  • Cardiovascular Science
  • Inflammation Research
  • Pharmacology

Background:

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) are associated with cardiovascular risk, partly due to suppression of cyclooxygenase 2 (COX-2)-derived prostacyclin (PGI(2)).
  • Conventional COX-2 knockout mice exhibit developmental defects, limiting their use in studying chronic NSAID effects.
  • Understanding the role of COX-2 in atherogenesis is crucial for mitigating NSAID-induced cardiovascular hazards.

Purpose of the Study:

  • To investigate the role of postnatal COX-2 deletion in promoting atherosclerosis.
  • To elucidate the mechanistic link between COX-2 inhibition and cardiovascular risk associated with NSAID use.

Main Methods:

  • Developed mice with postnatal deletion of COX-2 to bypass developmental issues.
  • Crossed these mice with ApoE-deficient hyperlipidemic mice to study atherogenesis.
  • Analyzed atherosclerotic lesions for leukocyte infiltration and vascular smooth muscle cell markers.
  • Examined peritoneal macrophages for prostanoid and lipoxygenase product formation.
  • Investigated the effect of 5-lipoxygenase activating protein (FLAP) deletion on atherogenesis.

Main Results:

  • Postnatal COX-2 deletion accelerated atherosclerosis in hyperlipidemic mice, with increased leukocyte infiltration and altered vascular smooth muscle cell phenotype.
  • COX-2 deletion led to suppressed COX-2-derived prostanoids and increased 5-lipoxygenase products in macrophages, indicating substrate rediversion.
  • Deletion of FLAP did not affect atherogenesis but attenuated the pro-atherogenic effects of COX-2 deletion.

Conclusions:

  • Postnatal COX-2 deletion promotes atherogenesis, providing a mechanistic explanation for the cardiovascular hazard of chronic NSAID use.
  • The findings suggest that NSAIDs may increase cardiovascular risk, particularly in individuals with pre-existing low risk.
  • Co-inhibition of FLAP may represent a strategy to mitigate NSAID-associated cardiovascular risks.

Related Concept Videos

Lipid Catabolism01:25

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
Inflammation01:38

Inflammation

Overview
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Lipid Digestion01:06

Lipid Digestion

Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...